Green James W.'s most recent trade in Harvard Bioscience Inc. was a trade of 38,413 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on March 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 19 Mar 2025 | 38,413 | 2,845,088 (7%) | 0% | 0.7 | 26,451 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Dec 2024 | 145,365 | 2,883,501 (7%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 29 Dec 2024 | 56,915 | 3,054,176 (8%) | 0% | 2.0 | 112,692 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. | 29 Dec 2024 | 25,310 | 3,028,866 (7%) | 0% | 2.0 | 50,114 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 13 Jun 2024 | 10,000 | 3,111,091 (8%) | 0% | 2.9 | 29,100 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.07 per share. | 06 Jun 2024 | 20,000 | 3,101,091 (8%) | 0% | 3.1 | 61,400 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 214,797 | 2,866,294 (7%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 214,797 | 3,081,091 (8%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | Green James W. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. | 29 Dec 2023 | 82,790 | 2,651,497 (6%) | 0% | 5.4 | 442,927 | Common Stock |
| Harvard Bioscience Inc. | Green W. James | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. | 29 Dec 2023 | 52,206 | 2,734,287 (7%) | 0% | 5.3 | 279,302 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. | 29 Dec 2023 | 28,783 | 2,809,709 (7%) | 0% | 5.3 | 153,989 | Common Stock |
| Harvard Bioscience Inc. | Green W. James | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. | 29 Dec 2023 | 24,187 | 2,838,492 (7%) | 0% | 5.3 | 129,400 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.35 per share. | 29 Dec 2023 | 23,216 | 2,786,493 (7%) | 0% | 5.4 | 124,206 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.38 per share. | 17 Aug 2023 | 25,000 | 2,862,679 (7%) | 0% | 4.4 | 109,500 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.46 per share. | 11 Jun 2023 | 48,373 | 2,837,679 (7%) | 0% | 5.5 | 264,117 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 14 Mar 2023 | 20,000 | 2,886,052 (7%) | 0% | 2.6 | 52,000 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 14 Mar 2023 | 20,000 | 2,866,052 (7%) | 0% | 2.7 | 53,400 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 353,140 | 2,506,442 (6%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 339,610 | 2,846,052 (7%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.77 per share. | 29 Dec 2022 | 49,322 | 2,153,302 (5%) | 0% | 2.8 | 136,622 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.55 per share. | 29 Dec 2022 | 28,784 | 2,225,840 (5%) | 0% | 2.5 | 73,399 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.55 per share. | 29 Dec 2022 | 24,187 | 2,254,624 (5%) | 0% | 2.6 | 61,677 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.55 per share. | 29 Dec 2022 | 23,216 | 2,202,624 (5%) | 0% | 2.6 | 59,201 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.61 per share. | 30 Nov 2022 | 15,000 | 2,278,811 (5%) | 0% | 2.6 | 39,150 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.41 per share. | 30 Nov 2022 | 15,000 | 2,263,811 (5%) | 0% | 2.4 | 36,150 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 17 Aug 2022 | 40,000 | 2,248,811 (5%) | 0% | 3.2 | 127,600 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.90 per share. | 08 Jul 2022 | 92,771 | 2,208,811 (5%) | 0% | 3.9 | 361,807 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.71 per share. | 15 Jun 2022 | 30,000 | 2,301,582 (6%) | 0% | 3.7 | 111,300 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.95 per share. | 11 Jun 2022 | 48,373 | 2,271,582 (5%) | 0% | 3.9 | 191,073 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.78 per share. | 06 May 2022 | 30,000 | 2,309,955 (6%) | 0% | 3.8 | 113,400 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 06 May 2022 | 10,000 | 2,319,955 (6%) | 0% | 3.4 | 34,000 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 157,037 | 2,134,590 (5%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 145,365 | 2,279,955 (5%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.05 per share. | 01 Jan 2022 | 47,424 | 1,977,554 (5%) | 0% | 7.0 | 334,339 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 7.27 per share. | 29 Dec 2021 | 28,783 | 2,024,978 (5%) | 0% | 7.3 | 209,252 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 7.27 per share. | 29 Dec 2021 | 24,187 | 2,053,761 (5%) | 0% | 7.3 | 175,839 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2021 | 13,777 | 2,077,948 (5%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.02 per share. | 23 Aug 2021 | 48,175 | 2,091,725 (5%) | 0% | 8.0 | 386,364 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.03 per share. | 08 Jul 2021 | 107,803 | 2,232,672 (5%) | 0% | 8.0 | 865,658 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.03 per share. | 08 Jul 2021 | 92,772 | 2,139,900 (5%) | 0% | 8.0 | 744,959 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 109,070 | 2,388,848 (6%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.64 per share. | 11 Jun 2021 | 48,373 | 2,340,475 (6%) | 0% | 7.6 | 369,570 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 21 May 2021 | 24,312 | 2,304,090 (6%) | 0% | 2.6 | 63,941 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.14 per share. | 21 May 2021 | 24,312 | 2,279,778 (5%) | 0% | 7.1 | 173,588 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2021 | 24,312 | 352,690 | - | - | Stock option (right to buy) | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 19 May 2021 | 39,188 | 2,318,966 (6%) | 0% | 2.6 | 103,064 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 39,188 | 391,878 | - | - | Stock option (right to buy) | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.17 per share. | 19 May 2021 | 39,188 | 2,279,778 (5%) | 0% | 7.2 | 280,978 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 14,876 | 377,002 | - | - | Stock option (right to buy) | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.03 per share. | 19 May 2021 | 14,876 | 2,279,778 (5%) | 0% | 7.0 | 104,578 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 19 May 2021 | 14,876 | 2,294,654 (6%) | 0% | 2.6 | 39,124 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 18 May 2021 | 39,188 | 2,318,966 (6%) | 0% | 2.6 | 103,064 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2021 | 39,188 | 431,066 | - | - | Stock option (right to buy) | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.41 per share. | 18 May 2021 | 39,188 | 2,279,788 (5%) | 0% | 7.4 | 290,383 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 12 Mar 2021 | 35,000 | 2,279,778 (5%) | 0% | 6.0 | 209,300 | Common Stock |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 194,698 | 2,128,104 (5%) | 0% | 0 | Common Stock | |
| Harvard Bioscience Inc. | James W. Green | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 186,674 | 2,314,778 (6%) | 0% | 0 | Common Stock |